GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, FABP3, FUT7, HMGCR, HSPA1A, IDO1, MIF, PIM1, PPARA, PTGS2, TYR, XDH |
14.467 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DHFR |
12.5361 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MMP2, NR3C1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TYR |
12.5361 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AKR1C3, APP, AR, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESRRA, FABP3, GSK3B, HMGCR, HSD17B2, IDO1, IGF1R, INSR, MMP2, MMP9, NR3C1, PPARA, PTGS2, RORC, SRC, TEK, TYR |
12.5361 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GSK3B, HMGCR, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TYR, XDH |
12.3641 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, ESR1, FABP3, FABP4, FUT7, HMGCR, HSD17B1, HSD17B2, MET, MIF, PPARA, PTGS2 |
12.3415 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.7954 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GSK3B, HMGCR, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP2, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TYR, XDH |
11.6522 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, AKR1C3, APP, AR, CSNK2A1, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FLT3, HMGCR, HSPA1A, IDO1, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, NUAK1, PGR, PIM1, PTGS2, SMAD3, SRC, TEK, XDH |
10.8885 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, FLT3, GPR35, GSK3B, HCAR2, HMGCR, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, PTGS2, SMAD3, SRC, TEK, XDH |
10.8595 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, FLT3, GPR35, GSK3B, HCAR2, HMGCR, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, PTGS2, SMAD3, SRC, TEK, XDH |
10.8531 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TYR |
10.8531 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF, PTGS2 |
10.0403 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, GSK3B, HMGCR, HSD17B1, HSD17B2, IDO1, PTGS2, TYR, XDH |
9.85916 |
[BP] GO:0006690 |
icosanoid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF, PTGS2 |
9.73655 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
9.61841 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FLT3, GPR35, GSK3B, HCAR2, HMGCR, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, XDH |
9.54129 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
AKR1C3, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2 |
9.44145 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, AKR1C3, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, ESR1, HMGCR, HSD17B1, HSD17B2 |
9.44145 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DHFR, EGFR, ESR1, F10, FABP3, FABP4, FLT3, GPR35, GSK3B, HCAR2, HMGCR, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MET, MIF, PPARA, PTGS2, SMAD3, SRC, TEK, XDH |
9.22926 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, AKR1C3, APP, AR, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, GSK3B, IGF1R, INSR, MMP2, NR3C1, PPARA, PTGS2, SMAD3, SRC, TEK |
9.15877 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GPR35, GSK3B, HCAR2, HMGCR, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, XDH |
8.96911 |
[BP] GO:0033993 |
response to lipid
|
AKR1C3, AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD17B2, IDO1, NR3C1, PTGS2, RORC, SRC, TYR |
8.92081 |
[BP] GO:0014070 |
response to organic cyclic compound
|
AKR1C3, APP, AR, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESRRA, FLT3, NR3C1, PTGS2, RORC, SRC, TEK, TYR |
8.87828 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC, SRC |
8.84353 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AKR1C3, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GSK3B, HCAR2, HMGCR, HSPA1A, IDO1, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PTGS2, SMAD3, SRC, TEK, XDH |
8.68833 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, CSNK2A1, CYP1B1, EGFR, F10, FLT3, GPR35, GSK3B, HMGCR, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, PTGS2, SMAD3, SRC, TEK, XDH |
8.68053 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AKR1C3, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GSK3B, HCAR2, HMGCR, HSPA1A, IDO1, IGF1R, KDR, MET, MIF, MMP9, PIM1, PTGS2, SMAD3, SRC, TEK, XDH |
8.65146 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, GSK3B, HMGCR, HSPA1A, IDO1, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PTGS2, SMAD3, SRC, TEK |
8.62055 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, AKR1C3, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, FABP3, FABP4, FUT7, HMGCR, MET, MIF, PPARA, PTGS2 |
8.52568 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, GSK3B, HMGCR, HSPA1A, IDO1, IGF1R, KDR, MET, MIF, MMP9, PIM1, PTGS2, SMAD3, SRC, TEK |
8.48115 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, F10, FLT3, GPR35, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP9, NUAK1, PTGS2, SRC, TEK, XDH |
8.48115 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, CYP1B1, EGFR, F10, FLT3, GPR35, HMGCR, HSPA1A, INSR, KDR, MET, MIF, PTGS2, SRC, TEK, XDH |
8.44988 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF, PTGS2 |
8.12671 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, CSNK2A1, CYP1B1, EGFR, ESRRA, F10, FABP4, FLT3, GPR35, GSK3B, HMGCR, HSPA1A, IDO1, INSR, KDR, MET, MIF, MMP12, MMP2, MMP9, PTGS2, SMAD3, SRC, TEK, XDH |
8.12615 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AKR1C3, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GSK3B, HCAR2, HMGCR, HSPA1A, IDO1, IGF1R, KDR, MIF, MMP9, PIM1, PTGS2, SMAD3, SRC, TEK, XDH |
8.02491 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPR35, GSK3B, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PTGS2, SMAD3, SRC, TEK, XDH |
7.87592 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC, SRC |
7.81676 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, AKR1C3, AR, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, INSR, NR3C1, PPARA, PTGS2, SRC, TEK |
7.81175 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, GSK3B, HMGCR, HSPA1A, IDO1, IGF1R, KDR, MIF, MMP9, PIM1, PTGS2, SMAD3, SRC, TEK |
7.77952 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPR35, GSK3B, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PTGS2, SMAD3, SRC, TEK, XDH |
7.74637 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, PGR, PIM1, PPARA, RORC, SRC |
7.63532 |
[BP] GO:0006631 |
fatty acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, MIF, PPARA, PTGS2 |
7.49273 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, PTGS2, RORC, SMAD3, SRC |
7.43268 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
AKR1C3, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2 |
7.28493 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GSK3B, HMGCR, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TYR, XDH |
7.24437 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AKR1C3, ALOX15, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, PTGS2, SRC |
7.20537 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, PIM1, SRC, TEK |
7.16782 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, CA2, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GSK3B, HMGCR, HSD17B2, INSR, KDR, MET, MIF, MMP2, MMP9, PGR, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TYR |
7.11508 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 |
7.02077 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AKR1C3, AR, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, INSR, KDR, PPARA, SMAD3, SRC, TEK, TYR |
7.00934 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, F10, FABP4, FLT3, GPR35, GSK3B, HMGCR, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP2, MMP9, NUAK1, PPARA, PTGS2, SMAD3, SRC, TEK, XDH |
6.88221 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CYP19A1, DHFR, DUSP3, EGFR, ESR1, FABP4, GSK3B, HMGCR, HSPA1A, IDO1, IGF1R, MET, MIF, MMP12, MMP2, NUAK1, PPARA, PTGS2, SMAD3, SRC, TEK, XDH |
6.86321 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, FLT3, GSK3B, IGF1R, INSR, KDR, MMP2, NR3C1, PTGS2, RORC, SMAD3, SRC |
6.8363 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC |
6.8363 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, CA2, CA6, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESRRA, F10, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, NR3C1, NUAK1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TYR |
6.76744 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, GSK3B, HSD17B2, INSR, KDR, MMP9, PGR, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TYR |
6.63734 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DHFR, EGFR, HSPA1A, IDO1 |
6.49963 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GSK3B, HMGCR, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TYR, XDH |
6.49289 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, APP, AR, AXL, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRB, F10, FABP4, HMGCR, HSD17B2, IDO1, IGF1R, INSR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TYR |
6.43159 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, GSK3B, HCAR2, HMGCR, HSPA1A, IDO1, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, XDH |
6.38094 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MIF, MMP2, MMP9, NR3C1, NUAK1, PTGS2, RORC, SMAD3, SRC |
6.27882 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 |
6.27882 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ALOX15, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, GPR35, GSK3B, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, PPARA, PTGS2, SMAD3, SRC, TEK |
6.27752 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AKR1C3, APP, AR, AXL, CYP1B1, EGFR, ESR1, GSK3B, IGF1R, INSR, MMP2, MMP9, NR3C1, PTGS2, RORC, SRC |
6.18496 |
[BP] GO:0032787 |
None
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, IDO1, MIF, PPARA, PTGS2 |
6.12248 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, MIF, MMP9, PTGS2, SMAD3, SRC, TEK |
6.03259 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AKR1C3, AR, CSNK2A1, EGFR, ESR1, FLT3, HMGCR, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PTGS2, TEK |
5.99205 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPR35, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PTGS2, SMAD3, SRC, TEK, XDH |
5.8905 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC |
5.8905 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, GSK3B, HMGCR, HSPA1A, IDO1, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, XDH |
5.86875 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, EGFR, ESR1, HCAR2, HMGCR, HSD17B1, HSD17B2 |
5.81817 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, AKR1C3, ALOX15, APP, AR, AURKB, CSNK2A1, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, XDH |
5.81652 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AKR1C3, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, FABP3, FABP4, FUT7, GSK3B, HSPA1A, IDO1, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
5.74407 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
AKR1C3, APP, AR, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, NR3C1, PTGS2, RORC, SRC |
5.74129 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, MIF, MMP9, PTGS2, SMAD3, SRC, TEK |
5.66441 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, AKR1C3, CYP1A1, FABP3, FLT3, HCAR2, HMGCR, PPARA, PTGS2, RORC, SRC, TEK |
5.58732 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.54671 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, AKR1C3, ALOX15, APP, AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, XDH |
5.4551 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, FABP3, IDO1, MIF, PIM1, PPARA, PTGS2, TYR |
5.41553 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX15, AR, CYP19A1, DUSP3, EGFR, ESR1, ESR2, GSK3B, HMGCR, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PTGS2, SMAD3, SRC, TEK, XDH |
5.38895 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, HMGCR |
5.29851 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, AKR1C3, APP, AR, AURKB, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PTGS2, RORC, SMAD3, SRC, XDH |
5.27058 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ALOX15, APP, AR, AURKB, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, XDH |
5.25325 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, MIF, MMP9, PTGS2, SMAD3, SRC, TEK |
5.20684 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, MIF, MMP9, PTGS2, SMAD3, SRC, TEK |
5.18935 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.15991 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, AKR1C3, APP, AR, EGFR, ESR1, FLT3, GSK3B, IGF1R, INSR, MMP2, NR3C1, PTGS2, SMAD3, SRC |
5.15204 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.1072 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, AR, DUSP3, EGFR, ESR1, ESR2, GPR35, GSK3B, HMGCR, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, SMAD3, SRC, XDH |
5.07826 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, AR, DUSP3, EGFR, ESR1, ESR2, GPR35, GSK3B, HMGCR, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, SMAD3, SRC, XDH |
5.05952 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, APP, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DHFR, HMGCR, TYR |
5.03447 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA |
4.99579 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, APP, AR, EGFR, FLT3, HMGCR, INSR, KDR, MIF, SRC, TEK, XDH |
4.96273 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ALOX15, APP, AR, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, HMGCR, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PPARA, PTGS2, SMAD3, SRC, TEK, XDH |
4.92042 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, APP, AR, DUSP3, EGFR, FLT3, HMGCR, IGF1R, INSR, KDR, MIF, SRC, TEK, XDH |
4.90314 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ALOX15, APP, AR, AURKB, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, XDH |
4.87932 |
[BP] GO:0043436 |
oxoacid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, FABP3, IDO1, MIF, PIM1, PPARA, PTGS2, TYR |
4.87311 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ALOX15, APP, AR, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, HMGCR, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PPARA, PTGS2, SMAD3, SRC, TEK, XDH |
4.87311 |
[BP] GO:0071248 |
cellular response to metal ion
|
AKR1C3, ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
4.80754 |
[BP] GO:0044283 |
None
|
AKR1B1, AKR1C3, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP3A4, DHFR, HMGCR, IDO1, MIF, PTGS2 |
4.79413 |
[BP] GO:0006082 |
organic acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, FABP3, IDO1, MIF, PIM1, PPARA, PTGS2, TYR |
4.77284 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
4.76845 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AKR1C3, AXL, EGFR, F10, INSR, MET, SRC, TEK, XDH |
4.75724 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AKR1C3, AXL, EGFR, F10, INSR, MET, SRC, TEK |
4.73373 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, CYP3A4, HSD17B1, HSD17B2 |
4.72901 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ALOX15, APP, AR, EGFR, ESRRB, FABP3, FLT3, HMGCR, INSR, KDR, MIF, MMP9, PTGS2, SMAD3, SRC, TEK, XDH |
4.70808 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ALOX15, APP, AR, EGFR, ESRRB, FABP3, FLT3, HMGCR, INSR, KDR, MIF, MMP9, PTGS2, SMAD3, SRC, TEK, XDH |
4.70808 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DHFR, EGFR, FABP3, FLT3, GSK3B, IGF1R, INSR, MMP2, PPARA, PTGS2, SRC, TEK, TYR |
4.62625 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
4.62625 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, AKR1C3, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HMGCR, HSD17B1, HSD17B2, MIF, PTGS2 |
4.62625 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
4.59145 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AR, AXL, CA2, CYP1B1, EGFR, ESRRB, HCAR2, HMGCR, HSPA1A, IDO1, KDR, MET, MIF, MMP12, MMP9, PIM1, PTGS2, SMAD3, SRC, TEK |
4.57684 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GPR35, GSK3B, HCAR2, HMGCR, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TYR, XDH |
4.57525 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, CYP1B1, EGFR, MMP9, SRC |
4.57525 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, AKR1C3, ALOX15, CYP19A1, CYP3A4, DHFR, HMGCR, TYR |
4.55905 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
4.51871 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, HMGCR, IDO1, KDR, MET, MIF, MMP12, PPARA, PTGS2, SMAD3, TEK |
4.48649 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, AKR1C3, CYP19A1, HMGCR, IDO1 |
4.44916 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AR, AXL, CA2, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, GPR35, GSK3B, HCAR2, HMGCR, HSPA1A, IDO1, INSR, KDR, MET, MIF, MMP12, MMP9, PIM1, PTGS2, SMAD3, SRC, TEK, XDH |
4.4321 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
AKR1C3, CYP1B1, DHFR, EGFR, INSR, PTGS2, SMAD3, XDH |
4.4321 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, DUSP3, ESR1, FABP4, GPR35, GSK3B, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, SRC |
4.38527 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
AKR1C3, ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
4.3791 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
4.37329 |
[BP] GO:0010038 |
response to metal ion
|
AKR1C3, ALOX15, APP, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
4.30633 |
[BP] GO:0071383 |
None
|
AKR1C3, AR, EGFR, FLT3, NR3C1, SRC |
4.28842 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, AKR1C3, DHFR, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGS2, SRC |
4.27435 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, CYP1A1, DHFR, EGFR, PPARA, SMAD3 |
4.26291 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DHFR, EGFR, FABP3, FLT3, GSK3B, IGF1R, INSR, MMP2, PPARA, PTGS2, SRC, TEK, TYR |
4.25693 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HMGCR, MMP2, MMP9, PTGS2 |
4.22958 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, NR3C1, PGR, SRC |
4.16645 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, CYP3A4, HMGCR, HSD17B1, HSD17B2 |
4.16645 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ALOX15, APP, AR, DUSP3, EGFR, ESRRB, FABP4, FLT3, HMGCR, IGF1R, INSR, KDR, MIF, MMP9, PPARA, PTGS2, SRC, TEK, XDH |
4.10719 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, APP, AURKB, AXL, CSNK2A1, DHFR, DUSP3, EGFR, FLT3, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTGS2, SRC, TEK, XDH |
4.10134 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, AR, AURKB, CSNK2A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, FABP4, FLT3, GPR35, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, MET, MIF, MMP9, NUAK1, PIM1, PPARA, PTGS2, SMAD3, SRC, TEK, XDH |
4.07053 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AR, AURKB, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, FABP4, FLT3, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, MIF, MMP9, NUAK1, PTGS2, SMAD3, SRC, TEK, XDH |
4.05805 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AKR1C3, APP, AXL, CYP1B1, EGFR, HSPA1A, MMP9, PTGS2, SRC |
4.05192 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AKR1C3, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
4.02563 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ALOX15, APP, AR, EGFR, ESRRB, FLT3, HMGCR, INSR, KDR, MIF, MMP9, PTGS2, SRC, TEK, XDH |
3.99086 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, GSK3B, IGF1R, INSR, PPARA, PTGS2, SRC, TEK |
3.99086 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, EGFR, HMGCR, KDR, MIF, SRC, TEK |
3.98261 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, AKR1C3, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
3.96959 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.93377 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APP, AR, AURKB, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, HMGCR, HSPA1A, IGF1R, KDR, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PTGS2, RORC, SMAD3, SRC, XDH |
3.92969 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DHFR, DUSP3, EGFR, GSK3B, HMGCR, HSPA1A, IGF1R, MET, MIF, NUAK1, PTGS2, XDH |
3.92969 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA |
3.92969 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DUSP3, EGFR, HMGCR, KDR, MIF, SRC, TEK |
3.92969 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, EGFR, HMGCR, HSPA1A, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK, TYR |
3.92969 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ALOX15, APP, AXL, CA2, CA7, CYP19A1, EGFR, GPR35, GSK3B, HCAR2, HMGCR, HSPA1A, INSR, MIF, MMP12, MMP9, PPARA, PTGS2, SMAD3, SRC |
3.92788 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, CYP1A1, EGFR, ESR1, FLT3, MET, MIF, PIM1, SRC, TEK, TYR |
3.90492 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
AKR1C3, EGFR, INSR, PTGS2, SMAD3, XDH |
3.84912 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, EGFR, ESR1, GSK3B, PGR, PPARA, RORC, SRC |
3.81323 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, APP, AURKB, AXL, CSNK2A1, DHFR, DUSP3, EGFR, FLT3, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTGS2, SRC, TEK, XDH |
3.80255 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, HSPA1A, IDO1, MMP12, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
3.77623 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AR, AURKB, AXL, ESR1, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK |
3.74848 |
[BP] GO:0010906 |
None
|
ESRRB, GSK3B, INSR, PPARA, RORC, SRC |
3.69754 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, EGFR, HCAR2, HMGCR, KDR, MIF, PTGS2, SRC |
3.69569 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
AR, DUSP3, EGFR, ESR1, ESR2, GSK3B, HMGCR, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, SMAD3, SRC, XDH |
3.69376 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.69376 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.69376 |
[BP] GO:0048545 |
response to steroid hormone
|
AKR1C3, AR, CA2, EGFR, FLT3, NR3C1, PTGS2, SRC |
3.68762 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ALOX15, APP, AR, CSNK2A1, EGFR, ESR1, FLT3, GSK3B, HMGCR, HSPA1A, INSR, KDR, MIF, MMP9, PTGS2, SMAD3, SRC, TEK, XDH |
3.68186 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.6729 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, AKR1C3, ALOX15, APP, AR, AURKB, CA9, CSNK2A1, CYP1A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GSK3B, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, XDH |
3.66767 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, AKR1C3, ALOX15, APP, AR, AURKB, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GSK3B, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, XDH |
3.66629 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, IDO1, PPARA, PTGS2, SMAD3, TEK |
3.64177 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.63758 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.59732 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, AKR1C3, APP, AR, AXL, CBR1, CYP1A1, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, GSK3B, HMGCR, KDR, MET, MIF, MMP2, MMP9, PGR, PTGS2, RORC, SMAD3, SRC, TEK |
3.58712 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, AR, EGFR, FLT3, HMGCR, INSR, KDR, MIF, MMP9, PTGS2, SRC, TEK, XDH |
3.58712 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, AKR1C3, APP, AR, AXL, CYP19A1, CYP1A1, EGFR, ESR1, ESRRB, HSD17B2, IDO1, INSR, MMP2, MMP9, PGR, PTGS2, SRC |
3.56683 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, KDR, MET, MMP12, NR3C1, PGR, PPARA, PTGS2, RORC, SMAD3, SRC |
3.56575 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
AKR1C3, AR, AXL, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, PGR, PTGS2, SRC |
3.5576 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
AKR1C3, APP, AR, AURKB, CSNK2A1, DHFR, DUSP3, ESR1, ESR2, ESRRA, FABP4, GSK3B, HMGCR, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, NR3C1, PPARA, PTGS2, RORC, SMAD3, SRC, XDH |
3.5417 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, SRC, TEK |
3.53204 |
[BP] GO:0044598 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.53204 |
[BP] GO:0044597 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.53204 |
[BP] GO:0030638 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.53204 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CYP19A1, EGFR, GSK3B, HCAR2, INSR, MIF, MMP12, PTGS2, SMAD3, SRC |
3.51253 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, AR, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, KDR, MIF, MMP9, PTGS2, SRC, TEK, XDH |
3.48776 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ALOX15, APP, AR, EGFR, ESR1, FLT3, GSK3B, HMGCR, HSPA1A, INSR, KDR, MIF, MMP9, PTGS2, SMAD3, SRC, TEK, XDH |
3.46974 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, CA9, CYP1A1, CYP1B1, DHFR, EGFR, FABP3, HMGCR, KDR, NR3C1, PTGS2, SRC |
3.42112 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DUSP3, ESR1, HMGCR, HSPA1A, IGF1R, MET, MIF, MMP9, PTGS2, SRC, XDH |
3.40901 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AKR1C3, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, FABP3, FABP4, FUT7, GSK3B, HSPA1A, IDO1, XDH |
3.3884 |
[BP] GO:0030647 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.38566 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, AOX1, APP, AR, AURKB, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DHFR, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, GSK3B, HMGCR, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, SMAD3, SRC, TEK, TYR, XDH |
3.38243 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, AKR1C3, APP, AR, AXL, CA1, CA2, CSNK2A1, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, GSK3B, HCAR2, IGF1R, INSR, KDR, MET, MIF, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, RORC, SMAD3, SRC, TEK |
3.376 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, CYP1B1, EGFR, MMP9, SRC |
3.37591 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4, RORC |
3.34796 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, AKR1C3, HMGCR |
3.34138 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, EGFR, NR3C1, SRC |
3.31631 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
AKR1C3, CYP1A2, EGFR, MMP9 |
3.28623 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, HMGCR, IGF1R, INSR, MIF, SRC |
3.27874 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.24821 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
3.23453 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, EGFR, PTGS2 |
3.21267 |
[BP] GO:0010675 |
None
|
ESRRB, GSK3B, INSR, PPARA, RORC, SRC |
3.21267 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.18523 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ALOX15, APP, AR, DUSP3, EGFR, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PTGS2, SRC, TEK, XDH |
3.18329 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PTGS2, SRC, TEK |
3.17689 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AR, AXL, CA2, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, GSK3B, HMGCR, IDO1, INSR, KDR, MIF, NUAK1, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, XDH |
3.1689 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, MET, MMP12, NR3C1, PGR, PPARA, PTGS2, RORC, SMAD3, SRC |
3.15552 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, AKR1C3, ALOX15, APP, AR, AURKB, CA9, CSNK2A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, XDH |
3.15525 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
3.15359 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
3.14659 |
[BP] GO:0071396 |
cellular response to lipid
|
AKR1C3, AR, AXL, EGFR, ESR1, FLT3, NR3C1, RORC, SRC |
3.14231 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.13692 |
[BP] GO:0019371 |
None
|
AKR1C3, CBR1, PTGS2 |
3.13692 |
[BP] GO:0048608 |
reproductive structure development
|
AKR1C3, AR, AXL, CYP19A1, ESR1, HSD17B2, INSR, SRC |
3.12833 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, SMAD3, SRC, TEK |
3.12431 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HMGCR, MMP2, MMP9, PTGS2 |
3.09941 |
[BP] GO:0006066 |
None
|
AKR1B1, AKR1B10, AKR1C3, APP, CYP1B1, CYP3A4, DHFR, HMGCR |
3.06552 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, GSK3B, HSPA1A, IDO1, MIF, MMP2, MMP9, NUAK1, PPARA, PTGS2, SMAD3, SRC, TEK |
3.04831 |
[BP] GO:0051172 |
None
|
APP, AR, AURKB, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HMGCR, HSPA1A, IGF1R, MIF, MMP12, MMP9, NR3C1, PPARA, PTGS2, RORC, SMAD3, SRC, XDH |
3.0429 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
EGFR, FABP4, IDO1, KDR, MET, MIF, PTGS2, SMAD3 |
3.03633 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, IGF1R, INSR, KDR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SMAD3, SRC |
3.03424 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP3A4 |
3.02957 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, EGFR, GSK3B, HCAR2, HMGCR, MIF, MMP12, PTGS2, SMAD3, SRC |
3.02941 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APP, AXL, CA12, CA2, CA7, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, INSR, MET, SMAD3, SRC |
3.02329 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX15, ALOX5, MIF, PTGS2 |
3.02232 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
3.01387 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, EGFR, KDR, NR3C1, PTGS2, SRC |
3.01387 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ALOX15, APP, AR, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, FABP4, FLT3, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PTGS2, SMAD3, SRC, TEK, XDH |
3.01112 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, GSK3B, MET, MMP9, PPARA, SRC |
2.97435 |
[BP] GO:0051222 |
positive regulation of protein transport
|
ACHE, APP, EGFR, GSK3B, HCAR2, MIF, MMP12, PTGS2, SMAD3, SRC |
2.95767 |
[BP] GO:0016488 |
None
|
AKR1B10, AKR1C3 |
2.95767 |
[BP] GO:0016487 |
None
|
AKR1B10, AKR1C3 |
2.95767 |
[BP] GO:0016107 |
None
|
AKR1B10, AKR1C3 |
2.95767 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.95767 |
[BP] GO:0006714 |
None
|
AKR1B10, AKR1C3 |
2.95767 |
[BP] GO:1901655 |
None
|
AKR1B1, AR, EGFR, NR3C1, SRC |
2.9527 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AKR1C3, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, FABP3, FABP4, GSK3B, HSPA1A, IDO1, SRC, XDH |
2.94839 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.94635 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
2.93834 |
[BP] GO:2000106 |
regulation of leukocyte apoptotic process
|
AURKB, AXL, HCAR2, IDO1, MIF |
2.93566 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ALOX15, ESR1, GSK3B, HSPA1A, KDR, MET, MMP1, SMAD3, SRC, TEK |
2.93321 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ALOX15, APP, AR, AURKB, CA9, CSNK2A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, XDH |
2.93169 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.8783 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.8783 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, IGF1R, INSR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SMAD3, SRC |
2.86075 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
AKR1C3, CYP1B1, GSK3B, HCAR2, HMGCR, IDO1, MMP9, PTGS2, SMAD3, SRC, XDH |
2.85948 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.85904 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, EGFR, GSK3B, IGF1R, INSR, MMP2, PTGS2, SRC |
2.85161 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.84942 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
AKR1C3, CYP1B1, GSK3B, HCAR2, HMGCR, IDO1, MMP9, PTGS2, SMAD3, SRC, XDH |
2.8273 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, GSK3B, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
2.8157 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.80791 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ALOX15, APP, AR, AURKB, CA9, CSNK2A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, XDH |
2.7943 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, APP, AR, AURKB, DHFR, EGFR, ESR1, ESR2, FLT3, GSK3B, HSPA1A, INSR, MET, MIF, MMP9, SMAD3, SRC, TEK, XDH |
2.7943 |
[BP] GO:0031334 |
positive regulation of protein complex assembly
|
ALOX15, ESR1, GSK3B, HSPA1A, MET, MMP1, SRC |
2.76257 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, APP, EGFR, GSK3B, HCAR2, MIF, MMP12, PTGS2, SMAD3, SRC |
2.74198 |
[BP] GO:0001954 |
positive regulation of cell-matrix adhesion
|
GSK3B, KDR, SMAD3, TEK |
2.73744 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, EGFR, F10, FLT3, GSK3B, IGF1R, INSR, KDR, MET, SRC, TEK |
2.73645 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.73265 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, DUSP3, EGFR, FABP4, FLT3, GSK3B, HMGCR, IGF1R, INSR, MIF, SRC, TEK |
2.72408 |
[BP] GO:0031960 |
response to corticosteroid
|
AKR1C3, EGFR, FLT3, NR3C1, PTGS2, SRC |
2.70911 |
[BP] GO:0003018 |
None
|
ADORA1, EGFR, HMGCR, PTGS2, SRC, TEK |
2.70911 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.70373 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX15, ALOX5, PTGS2 |
2.70373 |
[BP] GO:0010629 |
None
|
APP, AR, AURKB, DHFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, KDR, MIF, MMP12, NR3C1, PGR, PPARA, RORC, SMAD3, SRC, XDH |
2.69348 |
[BP] GO:2000107 |
negative regulation of leukocyte apoptotic process
|
AURKB, AXL, IDO1, MIF |
2.67646 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
HSPA1A, MIF, MMP9, PTGS2, SRC |
2.66906 |
[BP] GO:0016101 |
None
|
AKR1B10, AKR1C3, CYP1A1, CYP1B1, EGFR |
2.62676 |
[BP] GO:0051254 |
None
|
APP, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, INSR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SMAD3, SRC |
2.62215 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, EGFR, GSK3B, IGF1R, INSR, MMP2, PTGS2, SRC |
2.61339 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
2.61339 |
[BP] GO:0050678 |
None
|
AR, EGFR, KDR, MMP12, PGR, SMAD3, TEK, XDH |
2.60276 |
[BP] GO:0048732 |
gland development
|
AR, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
2.58781 |
[BP] GO:0000904 |
cell morphogenesis involved in differentiation
|
AR, AXL, MET, SRC, TEK |
2.57105 |
[BP] GO:0010942 |
positive regulation of cell death
|
AKR1C3, CYP1B1, GSK3B, HCAR2, HMGCR, IDO1, MMP9, PTGS2, SMAD3, SRC, XDH |
2.56649 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.56308 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, EGFR, INSR, KDR, NR3C1, SMAD3, SRC |
2.56308 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.56308 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.56308 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.56308 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.56308 |
[BP] GO:0060748 |
None
|
AR, PGR |
2.56308 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.56308 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.56308 |
[BP] GO:0016095 |
None
|
AKR1B10, AKR1C3 |
2.56308 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AR, AXL, CYP1A1, EGFR, ESR1, PGR, PTGS2, SRC |
2.54661 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX15, CYP1B1, DUSP3, GSK3B, IDO1, KDR, NUAK1, PPARA, SMAD3, SRC, TEK |
2.53861 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ALOX15, APP, AR, EGFR, FLT3, HMGCR, INSR, KDR, MIF, MMP9, PTGS2, SRC, TEK, XDH |
2.53861 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.53639 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.53639 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
GSK3B, KDR, SMAD3, SRC, TEK |
2.53491 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, GSK3B, MET, MMP9, PPARA, SMAD3, SRC |
2.51525 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
AKR1C3, AR, EGFR, ESR1, FLT3, INSR, NR3C1, SRC |
2.51525 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, MMP12, PPARA, SMAD3, TEK |
2.51525 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ALOX15, APP, AXL, CA2, CYP19A1, DUSP3, ESR1, ESRRA, HCAR2, HSPA1A, IDO1, MIF, MMP12, MMP2, SMAD3, SRC |
2.4932 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.48412 |
[BP] GO:0010811 |
positive regulation of cell-substrate adhesion
|
ALOX15, GSK3B, KDR, SMAD3, TEK |
2.48412 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.48412 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.48412 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DHFR, EGFR, INSR, PTGS2, SMAD3 |
2.48412 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, EGFR, HCAR2, MIF, MMP12, SRC |
2.48412 |
[BP] GO:0006109 |
regulation of carbohydrate metabolic process
|
ESRRB, GSK3B, INSR, PPARA, RORC, SRC |
2.48408 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, ALOX15, APP, AR, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, FABP4, FLT3, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PTGS2, SMAD3, SRC, TEK, XDH |
2.47824 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, CA12, CA2, CA7, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, MET, SMAD3 |
2.47264 |
[BP] GO:1901361 |
None
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP2A6, CYP3A4, HSPA1A, IDO1, XDH |
2.4639 |
[BP] GO:0046686 |
response to cadmium ion
|
AKR1C3, CYP1A2, EGFR, MMP9 |
2.42953 |
[BP] GO:0048729 |
tissue morphogenesis
|
AR, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.42815 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.40273 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.40273 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.39692 |
[BP] GO:0046394 |
None
|
ALOX15, ALOX5, CYP1A1, DHFR, IDO1, MIF, PTGS2 |
2.38056 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, AR, CYP1B1, FABP3, HSPA1A, IDO1, PTGS2, SMAD3, XDH |
2.37652 |
[BP] GO:0016053 |
None
|
ALOX15, ALOX5, CYP1A1, DHFR, IDO1, MIF, PTGS2 |
2.37328 |
[BP] GO:0045893 |
None
|
APP, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SMAD3, SRC |
2.37328 |
[BP] GO:1903508 |
None
|
APP, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SMAD3, SRC |
2.37328 |
[BP] GO:1902680 |
None
|
APP, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SMAD3, SRC |
2.3708 |
[BP] GO:0051248 |
None
|
APP, CSNK2A1, DHFR, DUSP3, EGFR, FABP4, HMGCR, HSPA1A, IGF1R, MIF, MMP9, PTGS2, SMAD3, SRC, XDH |
2.3708 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
APP, AR, AXL, CA2, CYP1B1, EGFR, ESR1, ESRRA, GSK3B, HMGCR, IDO1, INSR, KDR, PIM1, PTGS2, SMAD3, SRC, TEK, XDH |
2.37033 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AR, AXL, CA2, CYP1B1, ESRRB, HMGCR, IDO1, INSR, KDR, PIM1, PTGS2, SMAD3, SRC, TEK |
2.36146 |
[BP] GO:0001503 |
ossification
|
ALOX15, EGFR, MMP2, MMP9, TEK |
2.36018 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.34713 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.34557 |
[BP] GO:0051186 |
None
|
AKR1B1, AKR1B10, AKR1C3, CYP1A1, CYP1A2, DHFR, EGFR, HMGCR, PTGS2 |
2.3424 |
[BP] GO:0071384 |
None
|
AKR1C3, EGFR, FLT3, NR3C1 |
2.33339 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, AOX1, APP, AR, AURKB, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FLT3, FUT7, GSK3B, HMGCR, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TYR, XDH |
2.33222 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
ALOX15, GSK3B, KDR, SMAD3, SRC, TEK |
2.32794 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CYP1A1, DUSP3, EGFR, INSR, MIF, SRC |
2.3241 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.3241 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.3241 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.3241 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, MIF, SRC, TEK |
2.31944 |
[BP] GO:0009889 |
regulation of biosynthetic process
|
ADORA3, AKR1C3, APP, AR, AURKB, CA9, CSNK2A1, CYP1B1, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NR3C1, NR3C2, PGR, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC |
2.3152 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.3098 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, HMGCR, MIF, PPARA, SMAD3, TEK |
2.28685 |
[BP] GO:0070848 |
response to growth factor
|
APP, EGFR, INSR, KDR, NR3C1, SMAD3, SRC |
2.28685 |
[BP] GO:0007584 |
response to nutrient
|
AKR1C3, CYP1A1, EGFR, HMGCR, PTGS2, TYR |
2.28364 |
[BP] GO:0044249 |
None
|
ACHE, AKR1B1, AKR1C3, ALOX15, ALOX5, AR, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, HMGCR, HSD17B1, HSD17B2, IDO1, MIF, NR3C1, NR3C2, PGR, PPARA, PTGS2, RORC, SMAD3, TYR |
2.28364 |
[BP] GO:0006766 |
vitamin metabolic process
|
AOX1, CBR1, CYP1A1, CYP3A4, DHFR |
2.26833 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.26366 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.26366 |
[BP] GO:2001233 |
regulation of apoptotic signaling pathway
|
AR, GSK3B, HSPA1A, MIF, MMP9, PTGS2, SMAD3, SRC |
2.26366 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, EGFR, HCAR2, MIF, MMP12, SRC |
2.25685 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.22756 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, PTGS2 |
2.22445 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, AR, CYP1B1, ESR1, ESR2, HSPA1A, PIM1 |
2.21329 |
[BP] GO:1901360 |
None
|
ACHE, AKR1B1, AKR1B10, AKR1C3, AOX1, APP, AR, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, ESR1, ESR2, ESRRA, ESRRB, HMGCR, HSD17B1, HSD17B2, HSPA1A, IDO1, NR3C1, NR3C2, PGR, PPARA, PTGS2, RORC, SMAD3, TYR, XDH |
2.19361 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, HMGCR, IGF1R, INSR, MIF, SRC |
2.18252 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.17181 |
[BP] GO:0005979 |
None
|
ESRRB, GSK3B, INSR |
2.17181 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.17181 |
[BP] GO:0006693 |
None
|
AKR1C3, MIF, PTGS2 |
2.17181 |
[BP] GO:0006692 |
None
|
AKR1C3, MIF, PTGS2 |
2.17181 |
[BP] GO:0010962 |
None
|
ESRRB, GSK3B, INSR |
2.17181 |
[BP] GO:0001819 |
positive regulation of cytokine production
|
CYP1B1, HSPA1A, IDO1, MIF, MMP12, PTGS2, SMAD3, SRC |
2.1712 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, APP, AR, CSNK2A1, EGFR, GSK3B, HCAR2, HMGCR, MIF, MMP12, PTGS2, SMAD3, SRC |
2.16939 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, CA1, CSNK2A1, EGFR, FLT3, GPR35, GSK3B, IGF1R, INSR, KDR, MET, MIF, MMP2, MMP9, SMAD3, SRC, TEK |
2.16884 |
[BP] GO:0045913 |
None
|
ESRRB, INSR, PPARA, SRC |
2.16758 |
[BP] GO:0003013 |
None
|
ADORA1, EGFR, HMGCR, PTGS2, SRC, TEK |
2.16618 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, MMP9, PTGS2, SMAD3, SRC, XDH |
2.15867 |
[BP] GO:1900182 |
positive regulation of protein localization to nucleus
|
APP, EGFR, PTGS2, SMAD3, SRC |
2.15035 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
AKR1C3, CYP19A1 |
2.14898 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APP, GSK3B, IGF1R, INSR, SRC |
2.14273 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GSK3B, IGF1R |
2.13983 |
[BP] GO:0010628 |
positive regulation of gene expression
|
APP, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, GSK3B, HSPA1A, INSR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SMAD3, SRC |
2.13428 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, EGFR, PTGS2 |
2.12661 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, EGFR, PTGS2 |
2.12661 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, HSPA1A, MIF, MMP9, PTGS2, SRC |
2.11474 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ADORA1, ALOX15, AXL, CYP19A1, DUSP3, IDO1, MIF, MMP12 |
2.1113 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1 |
2.0986 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.09277 |
[BP] GO:0010632 |
regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
2.07622 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, DUSP3, EGFR, HMGCR, IGF1R, XDH |
2.07622 |
[BP] GO:0031099 |
regeneration
|
AXL, CSNK2A1, DHFR, EGFR, FLT3 |
2.07612 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.07528 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, CSNK2A1, EGFR, ESRRB, GSK3B, HCAR2, HSPA1A, INSR, KDR, MET, PPARA, SMAD3 |
2.07528 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.07528 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, DUSP3, EGFR, HMGCR, IGF1R, XDH |
2.07005 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.06906 |
[BP] GO:0033554 |
cellular response to stress
|
AKR1B1, AKR1C3, ALOX15, AXL, CA2, CA9, CYP1B1, DHFR, EGFR, GSK3B, HSPA1A, MIF, MMP9, NUAK1, PTGS2, SRC |
2.06575 |
[BP] GO:0070229 |
negative regulation of lymphocyte apoptotic process
|
AURKB, IDO1, MIF |
2.06575 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX15, MIF, PTGS2 |
2.06575 |
[BP] GO:0051223 |
None
|
ACHE, APP, EGFR, GSK3B, HCAR2, HMGCR, MIF, MMP12, PTGS2, SMAD3, SRC |
2.06227 |
[BP] GO:0000122 |
None
|
AR, AURKB, ESR1, ESR2, ESRRA, HSPA1A, MMP12, NR3C1, PPARA, RORC, SMAD3 |
2.05359 |
[BP] GO:0031349 |
positive regulation of defense response
|
EGFR, FABP4, HSPA1A, IDO1, MMP12, MMP2, PTGS2, SRC |
2.04403 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, MIF, SRC |
2.03158 |
[BP] GO:1900180 |
regulation of protein localization to nucleus
|
APP, EGFR, GSK3B, PTGS2, SMAD3, SRC |
2.03123 |
[BP] GO:0035265 |
organ growth
|
AR, CYP19A1, ESR1 |
2.03123 |
[BP] GO:0070873 |
None
|
ESRRB, GSK3B, INSR |
2.03123 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, SRC, TEK |
2.03123 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.03123 |
[BP] GO:1904645 |
response to amyloid-beta
|
APP, GSK3B, IGF1R |
2.03123 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.02528 |
[BP] GO:0010760 |
negative regulation of macrophage chemotaxis
|
CYP19A1, MIF |
2.01706 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.01706 |
[BP] GO:1990535 |
None
|
APP, INSR |
2.01706 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.01706 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX15, ALOX5 |
2.01706 |
[BP] GO:0016115 |
None
|
AKR1B10, AKR1C3 |
2.01706 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP3A4 |
2.01706 |
[BP] GO:0042060 |
None
|
ALOX15, EGFR, PPARA, SMAD3 |
2.01326 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, APP, AR, AURKB, CA1, CA2, CA4, CA5A, CA5B, CA7, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, DUSP3, EGFR, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, GSK3B, HMGCR, HSD17B1, HSD17B2, HSPA1A, IDO1, INSR, KDR, MIF, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PTGS2, SMAD3, SRC, TYR, XDH |
3.49187 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, TEK |
2.34682 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, F10, FLT3, HMGCR, HSD17B2, NR3C2, PTGS2 |
2.28364 |
[CC] GO:0045121 |
membrane raft
|
APP, EGFR, INSR, KDR, PTGS2, SRC, TEK |
2.17181 |
[CC] GO:0098857 |
membrane microdomain
|
APP, EGFR, INSR, KDR, PTGS2, SRC, TEK |
2.16571 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, AOX1, APP, AR, AURKB, AXL, CA1, CA2, CA4, CA5A, CA5B, CA6, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TYR, XDH |
2.11096 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, HMGCR, HSD17B2, NR3C2, PTGS2 |
2.06575 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, APP, AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, RORC, SMAD3, TYR, XDH |
23.2756 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
16.9341 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSD17B1, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TYR, XDH |
15.6879 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, DUSP3, EGFR, F10, FLT3, FUT7, GSK3B, HMGCR, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTGS2, SRC, TEK, TYR, XDH |
12.2474 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PPARA, RORC, SMAD3 |
11.5641 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.8731 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC |
10.6489 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, HMGCR, HSD17B1, HSD17B2, IDO1, PTGS2, TYR, XDH |
10.6381 |
[MF] GO:0005496 |
steroid binding
|
AR, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD17B1, NR3C1, NR3C2, PGR, RORC |
10.6149 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
9.66875 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, IDO1, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, RORC, SMAD3, TYR, XDH |
9.44145 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, IDO1, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, RORC, SMAD3, TYR, XDH |
9.123 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4 |
8.53563 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, PGR, PPARA, RORC |
8.24635 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PGR, PPARA, RORC |
8.24635 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, XDH |
8.00233 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, IDO1, PTGS2, SRC |
7.66664 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.49273 |
[MF] GO:0004497 |
monooxygenase activity
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, TYR |
7.46704 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, IDO1, PTGS2, SRC |
7.38422 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 |
7.11508 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, HMGCR, HSD17B1, IDO1, PTGS2, SRC, XDH |
6.97527 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, PTGS2, TYR |
6.94885 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AR, AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, HSD17B1, NR3C1, NR3C2, PGR, PPARA, RORC |
6.83575 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.75096 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
6.29177 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AKR1C3, AOX1, CBR1, HMGCR, HSD17B1, HSD17B2, XDH |
6.23319 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AR, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, TEK |
5.95006 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4, DHFR, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, SRC, TEK |
5.5814 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 |
5.42983 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.24736 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, EGFR, HSD17B1, IGF1R, INSR, NR3C1 |
5.1869 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AR, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, TEK |
5.09713 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AR, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, SMAD3, TEK |
5.03049 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AR, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, TEK |
4.88374 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.62625 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP3A4 |
4.57525 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, AKR1C3, CBR1, HMGCR, HSD17B1, HSD17B2 |
4.31446 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AKR1C3, AOX1, XDH |
4.06034 |
[MF] GO:0019899 |
enzyme binding
|
APP, AR, AURKB, CYP1A1, CYP1A2, CYP2A6, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRB, GSK3B, HMGCR, HSPA1A, MET, MIF, NR3C1, PGR, PPARA, PTGS2, SMAD3, SRC, TEK |
3.91079 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.79346 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ADORA1, AOX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HMGCR, HSD17B1, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP12, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, XDH |
3.66629 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX15, ALOX5, IDO1, PTGS2 |
3.55197 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX15, ALOX5, IDO1, PTGS2 |
3.49744 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
3.46008 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, AOX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HMGCR, HSD17B1, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP12, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, XDH |
3.44996 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.41772 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, SMAD3, SRC |
3.40159 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.38566 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.38566 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, APP, CSNK2A1, EGFR, ESR1, ESR2, FLT3, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PGR, PTGS2, SMAD3, TYR, XDH |
3.14659 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, SMAD3, SRC |
3.12431 |
[MF] GO:0045550 |
None
|
AKR1B10, AKR1C3 |
2.95767 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.95767 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.95767 |
[MF] GO:0043168 |
anion binding
|
ALOX15, AOX1, APP, AURKB, AXL, CSNK2A1, DHFR, EGFR, F10, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, XDH |
2.93827 |
[MF] GO:0008013 |
beta-catenin binding
|
AR, CSNK2A1, ESR1, GSK3B, SMAD3 |
2.93566 |
[MF] GO:0000978 |
None
|
AR, ESR1, ESR2, ESRRA, NR3C1, PGR, PPARA, RORC, SMAD3 |
2.85886 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AOX1, AURKB, AXL, CSNK2A1, DHFR, EGFR, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, XDH |
2.76783 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.73744 |
[MF] GO:0000987 |
None
|
AR, ESR1, ESR2, ESRRA, NR3C1, PGR, PPARA, RORC, SMAD3 |
2.72745 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.56308 |
[MF] GO:0047718 |
None
|
AKR1B10, AKR1C3 |
2.56308 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.56308 |
[MF] GO:0031072 |
heat shock protein binding
|
ADORA1, CSNK2A1, HSPA1A, KDR, NR3C1 |
2.49982 |
[MF] GO:0001085 |
RNA polymerase II transcription factor binding
|
AR, ESR1, GSK3B, PPARA, SMAD3 |
2.33222 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.3241 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.3241 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.3241 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.3241 |
[MF] GO:0000166 |
nucleotide binding
|
AOX1, AURKB, AXL, CSNK2A1, DHFR, EGFR, FLT3, GSK3B, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, XDH |
2.31791 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AOX1, AURKB, AXL, CSNK2A1, DHFR, EGFR, FLT3, GSK3B, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, XDH |
2.31612 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.27432 |
[MF] GO:0004033 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.17181 |
[MF] GO:0001012 |
None
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, PGR, PPARA, RORC, SMAD3 |
2.16226 |
[MF] GO:0000977 |
None
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, PGR, PPARA, RORC, SMAD3 |
2.16226 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.15035 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.14898 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.14898 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.14898 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1C3, HSD17B1, HSD17B2 |
2.13983 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
AKR1C3, HSD17B1, HSD17B2 |
2.06575 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.06575 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.01706 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.01706 |
[MF] GO:0047035 |
testosterone dehydrogenase (NAD+) activity
|
AKR1C3, HSD17B2 |
2.01706 |